Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2025-12-25 @ 12:12 AM
NCT ID:
NCT05313958
Eligibility Criteria:
Inclusion Criteria:
0-14 years old
Cytologically proven acute monocytic leukemia (M5) with other treatment
Exclusion Criteria:
Secondary to immunodeficiency or MDS
Second tumor
Dowm's syndrome
Evolution of chronic myelogenous leukemia to blast crisis
Death or quit treatment in seven days at the begining of induction therapy
Treatment with other effective chemotherapy drugs for AML, excluding the low dose chemotherapy for the purpose of reducing leukocytes in hyperleukocytic leukemia
Concurrent severe and/or uncontrolled medical condition (e.g. uncontrolled heart, brain, liver and kidney failure etc.)
Any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Month
Maximum Age:
14 Years
Study:
NCT05313958
Study Brief:
Protocol Section:
NCT05313958